Infection Prevention in Transplant Recipients.
- Author:
Young Eun HA
1
;
Kyong Ran PECK
Author Information
1. Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. krpeck@skku.edu
- Publication Type:Review
- Keywords:
Cytomegalovirus;
Invasive candidiasis;
Invasive aspergillosis;
Pneumocystis pneumonia;
Hematopoietic stem-cell transplantation;
Organ transplantation;
Vaccine
- MeSH:
Candidiasis, Invasive;
Cytomegalovirus;
Fungi;
Graft Rejection;
Graft vs Host Disease;
Humans;
Immunosuppression;
Immunosuppressive Agents;
Incidence;
Opportunistic Infections;
Organ Transplantation;
Pneumocystis jirovecii;
Pneumonia, Pneumocystis;
Transplants;
Vaccination
- From:Korean Journal of Medicine
2013;84(2):168-178
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Opportunistic infections are major causes of morbidity and mortality in hematopoietic stem-cell transplant and solid organ transplant recipients. The epidemiology and incidence of opportunistic infections in those patients have been dramatically changed with use of potent immunosuppressive agents as well as routine prophylaxis against various microorganisms such as common bacterial pathogens, fungi, cytomegalovirus, Pneumocystis jirovecii, and so on. Because transplant recipients are at the greatest risk for infection during early phase (1-3 months) after transplant, safe and effective prevention strategies should be implemented in this period. Moreover, beyond early phase, recipients are often susceptible to infections due to prolonged immunosuppressive therapy for graft rejection or chronic graft-versus-host diseases. Therefore, clinicians should assess a recipient's risk of infection on the basis of concomitant graft function, intensity of immunosuppression, and other factors that may contribute to susceptibility to infections. We discussed infection prevention strategies among recipients of hematopoietic stem-cell and solid organ transplantation against various opportunistic pathogens. Vaccinations should also be recommended for pre-transplant candidates and post-transplant recipients for the best prevention of infections.
